SLC2A5 and cancer: In CRC, S100P promotes metastasis by decreasing GLUT5 promoter methylation and activating transcription; elevated GLUT5 expression is strongly linked to enhanced invasiveness and metastatic potential, underscoring its crucial role in cancer metabolism 132.